Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1

作者：Martin Reck, Tudor–Eliade Ciuleanu, Jong-Seok Lee, Michael Schenker, Bogdan Żurawski, Sang‐We Kim, Mauricio Mahave, Aurelia Alexandru, Solange Peters, Adam Płużański, Reyes Bernabe Caro, Helena Linardou, Jacobus A. Burgers, Makoto Nishio, Alex Martínez‐Martí, Koichi Azuma, Rita Axelrod, Luis Paz‐Ares, Suresh S. Ramalingam, Hossein Borghaei, Kenneth J. O’Byrne, Li Li, Judith Bushong, Ravi G. Gupta, Diederik J. Grootendorst, Laura J. Eccles, Julie R. Brahmer · 发表于：Journal of Thoracic Oncology · 年份：2023 · DOI：10.1016/j.jtho.2023.04.021 · 被引用次数：77 · 研究领域：Brain Metastases and Treatment、Lung Cancer Research Studies、Cancer Immunotherapy and Biomarkers